RxSight Inventory

RxSight (RXST) currently reports a inventory of $37M as of June 2026. That compares with $25M in the prior-year period — up 48.1% year over year. Use the charts on this page to explore RxSight's inventory history and peer comparisons.

RxSight's inventory increased from $25M to $37M — a 48.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

RxSight reported $37M in inventory as of June 2026. That compares with $25M in the prior-year period — up 48.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $37M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for RxSight, and consider following RXST for alerts when major investors trade the stock.

RxSight is classified in the Healthcare sector. On inventory, it currently shows $37M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RXST with unrelated industries.